Zomig
NDC Package 64896-682-30
Package Information
Zomig is zolmitriptan is used to treat migraines. Marketed by Amneal Pharmaceuticals, this product is identified by NDC 64896-682 and is authorized under FDA application NDA021450.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 64896 - Amneal Pharmaceuticals
- 64896-682 - Zomig
- 64896-682-30 - 1 BOTTLE, SPRAY in 1 CARTON / 1 SPRAY, METERED in 1 BOTTLE, SPRAY
- 64896-682 - Zomig
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (64896-682). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 64896-682-30 identifies a specific commercial package of 1 bottle, spray in 1 carton / 1 spray, metered in 1 bottle, spray of Zomig, labeled by Amneal Pharmaceuticals. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Amneal Pharmaceuticals on December 06, 2013. The current certification is valid through April 30, 2024.
What are the primary indications for this medication?
Zolmitriptan is used to treat migraines. It helps to relieve headache, pain, and other migraine symptoms (including nausea, vomiting, sensitivity to light/sound). Prompt treatment helps you return to your normal routine and may decrease your need for other pain medications. Zolmitriptan belongs to a class of drugs known as triptans. It affects a certain natural substance (serotonin) that causes narrowing of blood vessels in the brain. It may also relieve pain by affecting certain nerves in the brain. Zolmitriptan does not prevent future migraines or lessen how often you get migraine attacks.
How is this Amneal Pharmaceuticals product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 64896068230. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.